Literature DB >> 26019629

Rapid identification of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.

Samy Selim1, Iman El Kholy2, Nashwa Hagagy3, Sahar El Alfay3, Mohamed Abdel Aziz3.   

Abstract

Twenty clinical Pseudomonas aeruginosa isolates recovered from patients admitted to The General Hospital in Ismailia Governorate (Egypt) were examined in this study. We analysed P. aeruginosa ATCC 9027 (as a control strain) and 19 of the isolates after digestion with SpeI restriction endonuclease. After this we conducted a pulsed-field gel electrophoresis (PFGE) and typed the obtained 10 unique patterns, designated as A, A1, B, B1, C, C1, D, D1, E and F. We evaluated the genetic relatedness between all strains, based on ≥87% band identity. As a result, the isolates were grouped in the 10 clusters as follows: patterns A, A1, B, B1, C contained two strains each and patterns C1, D, D1, E contained a single strain each; the five remaining strains were closely related (genomic pattern F). One isolate belonged to antibiotype 'b'. The genotype patterns of the P. aeruginosa ATCC 9027 control strain and isolate no. 11 were closely related and had two different antibiotypes 'd' and 'c', respectively.

Entities:  

Keywords:  Egypt; Pseudomonas aeruginosa; pulsed-field gel electrophoresis

Year:  2014        PMID: 26019629      PMCID: PMC4433924          DOI: 10.1080/13102818.2014.981065

Source DB:  PubMed          Journal:  Biotechnol Biotechnol Equip        ISSN: 1310-2818            Impact factor:   1.632


Introduction

Pseudomonas aeruginosa is a Gram-negative rod which does not ferment glucose. This micro-organism can be rarely observed as a part of the human microflora in healthy individuals. P. aeruginosa is the most important human pathogen from its genus. It may cause infections, particularly, in patients with cystic fibrosis, bronchiectasis, neutropenia, acquired immune deficiency syndrome (AIDS), burns and in those with metabolic, haematologic or malignant diseases.[1] P. aeruginosa is a major reason for nosocomial infections in patients who are in intensive care units, causing mainly ventilator-associated pneumonia, surgical site infections (SSIs), urinary tract infections and sepsis. It is also a poor prognosis marker, as it is associated with a higher mortality rate.[2] During the last decade, traditional phenotypic typing methods for epidemiologic and outbreak studies have been replaced by molecular methods.[3] Pulsed-field gel electrophoresis (PFGE) typing is one of the most useful discriminating methods to type Pseudomonas spp.[3,4] Although DNA-based techniques have proved successful in epidemiological studies of P. aeruginosa,[5] they are time consuming and expensive and require specific equipment.[6] That is why clinical laboratories commonly use antibiotic susceptibility and biochemical tests in routine analyses.[7-9] Quantitative analysis of antibiograms by comparing disk zone sizes is considered useful for nosocomial infection control in some cases.[10] Distinct biotypes can be determined by biochemical tests in combination with production of pigment and haemolysis. Although P. aeruginosa gives a uniform response in some biochemical tests used for identification purposes, the variability of the response to other tests can be used to distinguish clinical isolates based on different profiles (biotypes). In agar cultures, most P. aeruginosa strains form typical blue–green colonies due to the characteristic pigments pyocyanin and fluorescein. Some P. aeruginosa strains, however, can form colonies with a distinct colour due to other pigments, or can form even non-pigmented colonies.[7,11] In the present study, 20 clinical isolates of P. aeruginosa from hospitalized patients were evaluated for epidemiological relatedness. Two phenotypic methods (antibiotic susceptibility and biochemical patterns) and PFGE genotyping of DNA were used. Based on the obtained phenotypic and genotypic data, the accuracy of antibiotic profiles was evaluated and possible clonal relationships among the clinical isolates were analysed.

Materials and methods

Microbiological methods

Seven hundred patients from Public Ismailia Hospital (Egypt) were investigated. Samples from urine, wound discharge and burns were collected from these patients. Samples were handled by sterile swabs in clean dry and sterile containers. All collected samples were transferred into laboratory conditions within a few hours. The samples were streaked onto Cetrimide agar (Scharlau, Spain) and Nutrient agar and were incubated overnight under aerobic conditions at 37 °C to obtain individual colonies. The suspected P. aeruginosa colonies, which had green fluorescent colour, were picked up and purified. Gram-stained films of the single colonies were prepared and examined microscopically. Gram-positive micro-organisms (if present) were excluded from subsequent analyses. Gram-negative rods were further identified. In this study, we analysed 20 clinical isolates of P. aeruginosa recovered from patients and one P. aeruginosa ATCC (9027) strain used as the control. P. aeruginosa was identified on the basis of several characteristics, such as Gram staining, colony morphology, odour, production of pigment, oxidase test, growth on Kligler's medium slants (K/K),[12] urease production, growth on Cetrimide agar [13] and confirmation by API 20 NE kit test. The susceptibility tests were performed using the agar disk diffusion method, according to the guidelines of the National Committee for Clinical Laboratory Standards.[14] There are several different classes of antimicrobial agents commonly used and available for treatment of P. aeruginosa. In this study, we used aztreonam (ATM 30 μg), ceftazidime (CAZ 30 μg), ciprofloxacin (CIP 5 μg) and imipenem (IPM 10 μg). We classified the isolates as susceptible or resistant, based on the size of the zone of inhibition. In the susceptibility typing, the strains were classified as antibiotype ‘a’ (fully susceptible to antibiotics); antibiotype ‘b’ (multiresistant to three types of antibiotics); antibiotype ‘c’ (multiresistant to two types of antibiotics) and antibiotype ‘d’ (susceptible to three antibiotics, with a diameter of the clear zone ranging between 1.5 and 3.5 cm). Biotyping was performed by observation of haemolysis after growth on blood agar medium (Oxoid) for 24 h under transmitted light. Haemolytic isolates were divided into two groups, according to the observation of α or ß haemolysis. Production of pigment was determined on Mueller–Hinton medium (Scharlau, Spain) after incubation for 24 h at 35 °C and the pigmented colonies were classified according to their colour.

DNA genomic typing by PFGE

Macrorestriction analysis by PFGE of DNA was performed according to USA Centers for Disease Control and Prevention (CDC) highly standardized PFGE protocols [15] for Gram-negative rods with some minor modifications.[16] Bacterial suspensions were prepared from individual bacterial colonies directly obtained from cultures incubated overnight on Mueller–Hinton agar. The suspensions were adjusted to a concentration of 109 CFU/mL (colony-forming units per millilitre), which is equal to 1:1.5 NTU (Nephelometric Turbidity Unit) in ethylenediaminetetraacetic acid (EDTA)–saline buffer (75 mmol/L NaCl and 25 mmol/L EDTA, pH 7.5). The cell suspension was mixed with an equal volume of 1% low-melting point seaKem Gold Agarose (Cambrex Bio Sciences Rockland, Inc.) and was allowed to solidify in a 100 μL plug mould. The agarose plug was incubated for 24 h at 37 °C in 500 μL of lysis buffer (6 mmol/L Tris–HCl (pH 7.6), 0.1 mol/L EDTA, 1 mol/L NaCl, 0.5% Brij®58 (polyoxyethylene (20) cetyl ether; Sigma), 0.4% sodium deoxycholate, 0.5% sodium lauryl sarcosine and 1 mg/mL lysozyme). Next, the lysis buffer was replaced with 500 μL of proteinase K buffer (1% sodium lauryl sarcosine, 0.5 mol/L EDTA (pH 9) and proteinase K (50 μg/mL; Sigma)) and this solution was incubated with gentle shaking at 50 °C for 20 h. The plugs were then washed four times for 30 min at 37 °C with 10 mL of Tris–EDTA buffer (10 mmol/L Tris–HCl (pH 8) and 1 mmol/L EDTA). One-third of a slice of each plug was cut and incubated for 18–20 h with 30 U of SpeI (Bio-Rad Laboratories) in the restriction buffer (Promega Buffer). DNA restriction fragments were separated by PFGE by using a CHEF DR III apparatus (Bio-Rad, Richmond, CA, USA) at 14 °C, 6 V/cm, for 20 h, with a time switch of 2–40 s. A Salmonella serotype Branderup strain (H9812) ladder (Bio-Rad Laboratories) restricted with XbaI was used as a universal size marker.[17] The gel was stained with ethidium bromide and visualized with the Gel-Doc system (Bio-Rad Laboratories). According to the criteria by Tenover et al. [3], isolates were considered to be genetically indistinguishable or identical if the restriction fragments had the same number of bands and the corresponding bands were with identical apparent size. Therefore, these isolates were designated as genomic pattern A. Isolates were considered to be closely related if their PFGE patterns showed differences in two or three of their bands, consistent with a single genetic event, and those isolates were classified as genomic pattern A1. Isolates were possibly related if their PFGE patterns showed differences in four to six of their bands, associated with two independent genetic events, and those isolates were classified as genomic pattern A2. Isolates were considered to be unrelated if their PFGE patterns showed differences in seven or more of their bands, corresponding to three or more independent genetic events, and were designated as type A, A1, B, B1, C, C1, D, D1, E and F.

Results and discussion

Of the 20 clinical isolates, 10% were obtained from urine and the other 90% were obtained from different surgical wounds. Pigment production was observed in 16 of the isolates, most of which displayed the characteristic blue–green, yellowish-green and yellow colour (Table 1). All isolates were haemolytic and most of them demonstrated β-haemolysis (85.7%). The susceptibility typing classified only one isolate (No. 12) as antibiotype ‘a’; one isolate (No. 6) as antibiotype ‘b’; one isolate (No. 11) as antibiotype ‘c’ and the rest of the isolates (85.7%) as antibiotype ‘d’.
Table 1.

Major characteristics, antibiotic susceptibility and biochemical profiles observed in Pseudomonas aeruginosa clinical isolates.

   Zone of inhibition (cm)
  
Isolate no.SourceAntibiotypeCAZIPMATMCIPPigment productionHaemolysis
1Woundd032.23Yellowβ
2Woundd03.22.22.8Yellowβ
3Woundd031.52.5Yellowβ
4Woundd03.91.72.8Blue–greenβ
5Urined02.532Noneα
6Woundb02.300Yellowβ
7Woundd02.72.83.2Blue–greenβ
8Woundd02.81.82.7Yellowβ
9Urined03.62.42.7Rosy-brownβ
10Woundd02.82.63.2Yellowβ
11Woundc04.604.2Noneβ
12Wounda1.7323Noneβ
13Urined02.72.83.2No growthα
14Woundd031.82.5Blue–greenβ
15Woundd01.722.5No growthβ
16ATCC 9027d02.72.12.5Yellowish-green
17Woundd03.423.6Pale-yellowβ
18Woundd03.42.42.9Yellowβ
19Woundd03.42.53Yellowish-greenβ
20Woundd032.42.4Yellowish-greenβ
21Woundd03.32.82.9Yellowish-greenβ

Note: CAZ – ceftazidime (30 μg), IPM – imipenem (10 μg), ATM – aztreonam (30 μg), CIP – ciprofloxacin (30 μg); β – complete blood haemolysis, α – partial blood haemolysis. Antibiotype ‘a’ (fully susceptible to antibiotics), ‘b’ (multiresistant to three types of antibiotics), ‘c’ (multiresistant to two types of antibiotics) and ‘d’ (susceptible to three types of antibiotics with clear zone diameter ranging between 1.5 and 3.5 cm).

Major characteristics, antibiotic susceptibility and biochemical profiles observed in Pseudomonas aeruginosa clinical isolates. Note: CAZceftazidime (30 μg), IPMimipenem (10 μg), ATM – aztreonam (30 μg), CIPciprofloxacin (30 μg); β – complete blood haemolysis, α – partial blood haemolysis. Antibiotype ‘a’ (fully susceptible to antibiotics), ‘b’ (multiresistant to three types of antibiotics), ‘c’ (multiresistant to two types of antibiotics) and ‘d’ (susceptible to three types of antibiotics with clear zone diameter ranging between 1.5 and 3.5 cm). SpeI digestion of the 19 P. aeruginosa isolates from different patients and P. aeruginosa ATCC 9027 control strain were typed using PFGE (one isolate was eliminated during the analysis), giving 10 unique patterns (designated as pattern types A, A1, B, B1, C, C1, D, D1, E and F; Figure 1). When we compared the genetic relatedness (defined as ≥87% band identity) of the strains, they were grouped in the following 10 clusters: two strains in pattern A; two in pattern A1; two in pattern B, two in pattern B1, two in pattern C; patterns C1, D, D1, E contained single isolate each and the five remaining strains were closely related (genomic pattern F). We took the PFGE profiles as standard. We observed that genotype B1 included two distinct antibiotypes, ‘b’ and ‘d’. Genotypes A, A1, B and C contained two isolates and two different antibiotypes each. Patterns D1 and E contained one isolate. Genotype F included five isolates, which belonged to antibiotype ‘d’. Genotypes C1 and D contained a single isolate each and they had their own unique antibiotypes ‘c’ and ‘a’, respectively. The genotype pattern of the P. aeruginosa ATCC 9027 control strain and isolate no. 11 were closely related and had two different antibiotypes ‘d’ and ‘c’, respectively.
Figure 1.

DNA genomic patterns of Pseudomonas aeruginosa digested with SpeI. PFGE patterns A, A1, B, B1, C, C1, D, D1, E and F are shown.

Note: L: DNA ladder; Lanes 1–21: isolates (see Table 1); Lane 16 – P. aeruginosa ATCC 9027 control strain.

DNA genomic patterns of Pseudomonas aeruginosa digested with SpeI. PFGE patterns A, A1, B, B1, C, C1, D, D1, E and F are shown. Note: L: DNA ladder; Lanes 1–21: isolates (see Table 1); Lane 16 – P. aeruginosa ATCC 9027 control strain. Our results from DNA restriction enzyme analysis by PFGE (molecular typing) demonstrated that most P. aeruginosa isolates belonged to distinct genotypes, in agreement with previous reports [7] that this method has a higher discriminatory power than the phenotypic methods (antibiotyping and biotyping). Our results are also in support of the observation made by Freitas and Barth [7] that, although isolates with unique susceptibility profiles displayed distinct genotypes, the difference in antibiotype may not guarantee clonal distinction. This is due to the fact that many isolates of the same genotype may display distinct susceptibility profiles, which could question the adequacy of antibiotyping for typing purposes.[17,18] As a whole, it is not surprising that the discriminatory power of susceptibility tests is low, since it depends on the number of types defined by a method and the relative frequencies of these types.[7,19] Phenotypic methods can be used for initial screening of isolates which may be further typed by a more discriminatory test.[7,20-22] However, biotype, antibiotype or a combination of both may in some cases be insufficient for screening and typing of different genotypes.[7,14] The isolation of the same bacteria from patients in the same unit may be of help to detect an outbreak.[22] However, it has been shown that susceptibility profiles are not acceptable as a presumption of relatedness or distinction among P. aeruginosa isolates, indicating that a clonal relation can be identified only through DNA typing, such as PFGE-based typing.[7,14] This could explain why macrorestriction analysis of DNA by PFGE has become a widespread technique for typing bacterial isolates, which is further supported by the general applicability of this method to any species [23] and its powerful discriminatory potential for the classification of isolates.[22,23] For example, Römling and Tümmler [24] reported that the typeability, i.e., the percentage of strains that could be assigned a type, was 100%. PFGE is also a relatively inexpensive, fast and reproducible DNA typing tool for effective epidemiological surveillance of potentially transmissible P. aeruginosa isolates.[25] Hence, macrorestriction analysis has long been considered the method of choice for typing of P. aeruginosa isolates.[26,27]

Conclusions

The results from this study demonstrate the power of PFGE as a suitable, relatively inexpensive, fast, reproducible and highly discriminatory DNA-typing tool for analysis of potentially transmissible P. aeruginosa isolates.
  22 in total

1.  Antimicrobial susceptibility and serotyping of Pseudomonas aeruginosa strains isolated in Bogota, Columbia.

Authors:  B Rodríguez; E Vásquez; O Sussmann; S Máttar; C A Jaramillo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

2.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Epidemiologic Study of Pseudomonas aeruginosa in critical patients and reservoirs.

Authors:  A L Corona-Nakamura; M G Miranda-Novales; B Leaños-Miranda; L Portillo-Gómez; A Hernández-Chávez; J Anthor-Rendón; S Aguilar-Benavides
Journal:  Arch Med Res       Date:  2001 May-Jun       Impact factor: 2.235

5.  Concept of segmentation in nosocomial epidemiology: epidemiological relation among antimicrobial-resistant isolates of Pseudomonas aeruginosa.

Authors:  M Kinoshita; E Sawabe; N Okamura
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

6.  Value of phenotyping methods as an initial screening of Pseudomonas aeruginosa in epidemiologic studies.

Authors:  D Bergmans; M Bonten; F van Tiel; C Gaillard; N London; S van der Geest; P de Leeuw; E Stobberingh
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

7.  Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments.

Authors:  N Renders; U Römling; H Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Typing of Pseudomonas aeruginosa from hospitalized patients: a comparison of susceptibility and biochemical profiles with genotype.

Authors:  A L Freitas; A L Barth
Journal:  Braz J Med Biol Res       Date:  2003-12-18       Impact factor: 2.590

9.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System.

Authors:  W R Jarvis; J R Edwards; D H Culver; J M Hughes; T Horan; T G Emori; S Banerjee; J Tolson; T Henderson; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

View more
  5 in total

1.  Molecular epidemiology of Pseudomonas aeruginosa in University Clinical Center of Kosovo.

Authors:  Greta Lila; Gjyle Mulliqi; Lul Raka; Arsim Kurti; Rrezarta Bajrami; Elvir Azizi
Journal:  Infect Drug Resist       Date:  2018-10-26       Impact factor: 4.003

2.  Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a burn center.

Authors:  Pezhman Karami; Parviz Mohajeri; Rasool Yousefi Mashouf; Manoochehr Karami; Mojtaba Hedayat Yaghoobi; Dara Dastan; Mohammad Yousef Alikhani
Journal:  Saudi J Biol Sci       Date:  2018-07-20       Impact factor: 4.219

3.  Recent Advances in Molecular Diagnosis of Pseudomonasaeruginosa Infection by State-of-the-Art Genotyping Techniques.

Authors:  Jian-Woon Chen; Yin Yin Lau; Thiba Krishnan; Kok-Gan Chan; Chien-Yi Chang
Journal:  Front Microbiol       Date:  2018-05-28       Impact factor: 5.640

4.  Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota as causative agents of secondary bacterial infection in influenza patients.

Authors:  Tian Qin; Taoran Geng; Haijian Zhou; Yang Han; Hongyu Ren; Zhifeng Qiu; Xudong Nie; Tiekuan Du; Junrong Liang; Pengcheng Du; Wei Jiang; Taisheng Li; Jianguo Xu
Journal:  Emerg Microbes Infect       Date:  2020-03-17       Impact factor: 7.163

5.  An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Xuefei Zhang; Leilei Wang; Dan Li; Pei Li; Lili Yuan; Fan Yang; Qinglan Guo; Minggui Wang
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.